US equities
|
SPCX
$166.84
▲+4.96%
NVDA
$236.66
▲+1.16%
MU
$1,062.85
▼-1.12%
TSLA
$376.95
▲+1.72%
MSFT
$524.44
▲+1.34%
SNDK
$1,704.13
▼-0.92%
INTC
$117.34
▼-1.67%
META
$742.61
▲+2.00%
SPCX
$166.84
▲+4.96%
NVDA
$236.66
▲+1.16%
MU
$1,062.85
▼-1.12%
TSLA
$376.95
▲+1.72%
MSFT
$524.44
▲+1.34%
SNDK
$1,704.13
▼-0.92%
INTC
$117.34
▼-1.67%
META
$742.61
▲+2.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Rallybio
Rallybio Announces Pricing of $50 Million Public Offering
November 10, 2022
From
Rallybio
Via
Business Wire
Tickers
RLYB
Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
July 02, 2021
From
Rallybio
Via
Business Wire